Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer

AIM: To compare a test version of HFA fluticasone/salmeterol (FP/SM) combination inhaler (Neolab, UK) with the reference product Seretide (GlaxoSmithKline, UK). METHODS: An in vitro Anderson cascade impactor was used to compare the fine particle dose (<4.7 µm). Two separate randomized cross-over...

Full description

Saved in:

Bibliographic Details
Main Authors:	Clearie, Karine L, Williamson, Peter A, Vaidyanathan, Sriram, Du Bois, Jeannine, Nell, Haylene, Lipworth, Brian J
Format:	Artigo
Language:	Inglês
Published:	Blackwell Science Inc 2010
Subjects:	Pharmacokinetics
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2883756/ https://ncbi.nlm.nih.gov/pubmed/20565455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03655.x
Tags:	Add Tag No Tags, Be the first to tag this record!

Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer

Similar Items